Moreover, use of these IOLs has grown only 6% per year since 2010. New presbyopia-correcting IOLs, including accommodating and toric accommodating designs, are being developed with an eye toward expanding the stunted market.forecasts nearly 11% growth in presbyopia-correcting IOLs through the end of 2016 as new options become available. Presbyopia correction can be approached in a number of ways. For nearly two decades, “presbyopia-correcting” intraocular lenses (IOLs) have been available to post-cataract surgery patients, but for a variety of reasons they have garnered only modest interest.According to , presbyopia-correcting lenses only account for 2.4% of total IOLs implanted globally in 2014.
Con el fin de restaurar la visión de cerca, se han desarrollado e introducido diferentes dispositivos que producen múltiples focos.
Tekia, Inc., a privately owned medical device company, announced today that it has received a CE Mark approval from the European Union for its Accommodating Intraocular Lens.
The CE Mark approval allows Tekia to market its lens throughout the European Union.
During cataract surgery, your physician will replace your natural lens with an IOL.
Today there are multiple types of IOLs, each delivering a different performance profile based on how the lens is designed.